Literature DB >> 8384533

Genetic complementation reveals a novel regulatory role for 3' untranslated regions in growth and differentiation.

F Rastinejad1, H M Blau.   

Abstract

Differentiated skeletal muscle cells cease dividing and sustain expression of a battery of tissue-specific genes. To identify regulators of growth and differentiation, we used a genetic complementation approach. Following introduction of a cDNA expression library into a differentiation-defective myoblast mutant (NMU2), cDNAs were isolated that activated muscle-specific promoters. The complementing cDNAs were identified as muscle structural genes, troponin I, tropomyosin, and alpha-cardiac actin, and their activity was mapped to the 3' untranslated region (3'UTR). The 3'UTRs augmented the differentiation of wild-type muscle cells. Upon expression in 10T1/2 fibroblasts, proliferation was suppressed, indicating that the effects of the 3'UTRs are not limited to myogenic cells. These data suggest that 3'UTRs of certain differentiation-specific RNAs are trans-acting regulators in a feedback loop that inhibits cell division and promotes differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384533     DOI: 10.1016/0092-8674(93)90579-f

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  81 in total

1.  Modulation of cell proliferation by cytokeratins K10 and K16.

Authors:  J M Paramio; M L Casanova; C Segrelles; S Mittnacht; E B Lane; J L Jorcano
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  The 3'-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR.

Authors:  Jean M Nussbaum; Shobha Gunnery; Michael B Mathews
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

3.  Evidence for involvement of 3'-untranslated region in determining angiotensin II receptor coupling specificity to G-protein.

Authors:  Thomas J Thekkumkara; Stuart L Linas
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

4.  UM 9(5)h and UM 9(5)p, human and porcine noncoding transcripts with preferential expression in the cerebellum.

Authors:  Uwe Michel; Boris Kallmann; Peter Rieckmann; Dirk Isbrandt
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

5.  Expression of prohibitin 3' untranslated region suppressor RNA alters morphology and inhibits motility of breast cancer cells.

Authors:  Sharmila Manjeshwar; Megan R Lerner; Xiao-Ping Zang; Dannielle E Branam; J Thomas Pento; Mary M Lane; Stan A Lightfoot; Daniel J Brackett; Eldon R Jupe
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

6.  Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.

Authors:  Eugene P Toy; Masoud Azodi; Nancy L Folk; Christina M Zito; Caroline J Zeiss; Setsuko K Chambers
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

7.  Malignant transformation of colonic epithelial cells by a colon-derived long noncoding RNA.

Authors:  Jeffrey L Franklin; Carl R Rankin; Shawn Levy; Jay R Snoddy; Bing Zhang; Mary Kay Washington; J Michael Thomson; Robert H Whitehead; Robert J Coffey
Journal:  Biochem Biophys Res Commun       Date:  2013-09-14       Impact factor: 3.575

8.  Germ-line human epsilon heavy chain gene RNA transcripts utilize the full range of alternative 3' splicing seen in productive epsilon mRNA.

Authors:  K Zhang; D Diaz-Sanchez; A Saxon
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

9.  Interspecific sequence comparison of the muscle-myosin heavy-chain genes from Drosophila hydei and Drosophila melanogaster.

Authors:  K Miedema; H Harhangi; S Mentzel; M Wilbrink; A Akhmanova; M Hooiveld; P Bindels; W Hennig
Journal:  J Mol Evol       Date:  1994-10       Impact factor: 2.395

Review 10.  Role of CSF-1 in progression of epithelial ovarian cancer.

Authors:  Setsuko K Chambers
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.